(Q46922501)

26 December 2017

title

The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls (English)

1 reference

26 December 2017

author name string

Colin Palmer

1

1 reference

26 December 2017

Kathryn A Ellis

2

1 reference

26 December 2017

Barry V O'Neill

3

1 reference

26 December 2017

Rodney J Croft

4

1 reference

26 December 2017

Sumie Leung

5

1 reference

26 December 2017

Chris Oliver

6

1 reference

26 December 2017

Keith A Wesnes

7

1 reference

26 December 2017

Pradeep J Nathan

8

1 reference

26 December 2017

publication date

1 March 2008

1 reference

26 December 2017

published in

Human Psychopharmacology

1 reference

26 December 2017

volume

23

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

151-159

1 reference

26 December 2017

Schizophrenia, sensory gating, and nicotinic receptors

cites work

1 reference

Milacemide and Other Drugs Active at Glutamate NMDA Receptors as Potential Treatment for Dementia

21 January 2018

1 reference

Repeated dose comparison of nomifensine, imipramine and placebo on subjective assessments of sleep and objective measures of psychomotor performance

21 January 2018

1 reference

Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory.

21 January 2018

1 reference

Effects of NMDA Modulation in Scopolamine Dementiaa

21 January 2018

1 reference

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

Glycine prodrug facilitates memory retrieval in humans

21 January 2018

1 reference

Effects of An Oral Mixture Containing Glycine, Glutamine and Niacin on Memory, GH and IGF-I Secretion in Middle-aged and Elderly Subjects

21 January 2018

1 reference

7 January 2021

Cellular and subcellular localization of the inhibitory glycine receptor in hippocampal neurons

1 reference

7 January 2021

Characterization of the inhibitory glycine receptor on entorhinal cortex neurons

1 reference

7 January 2021

IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans

1 reference

7 January 2021

Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment.

1 reference

7 January 2021

Focus on protein kinase A and protein kinase C, critical components of signal transduction system, in mood disorders and suicide.

1 reference

7 January 2021

The metabolic response to ingested glycine.

1 reference

7 January 2021

A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia

1 reference

7 January 2021

Regional and cellular fractionation of working memory

1 reference

7 January 2021

Effects of endogenous agonists, glycine and D-serine, on in vivo specific binding of [11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors

1 reference

7 January 2021

Selective effects of acute serotonin and catecholamine depletion on memory in healthy women.

1 reference

7 January 2021

N-Methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade.

1 reference

7 January 2021

Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality

1 reference

7 January 2021

Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis

1 reference

7 January 2021

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

1 reference

7 January 2021

Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers.

1 reference

7 January 2021

Adjunctive high-dose glycine in the treatment of schizophrenia

1 reference

7 January 2021

The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers.

1 reference

7 January 2021

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

1 reference

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

7 January 2021

Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels

1 reference

7 January 2021

N-methyl-D-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review

1 reference

7 January 2021

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

1 reference

7 January 2021

Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

1 reference

7 January 2021

Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type

1 reference

7 January 2021

Cerebral metabolic effects of intravenous glycine in healthy human subjects.

1 reference

7 January 2021

NMDA receptor regulation of memory and behavior in humans

1 reference

7 January 2021

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

1 reference

7 January 2021

Selective cognitive impairments associated with NMDA receptor blockade in humans

1 reference

7 January 2021

Glycine-gated chloride channels depress synaptic transmission in rat hippocampus

1 reference

7 January 2021

High-Speed Scanning in Human Memory

1 reference

7 January 2021

Therapeutic trial with glycine in myoclonus

1 reference

7 January 2021

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

1 reference

7 January 2021

Practice effects on cognitive tasks: a major problem?

1 reference

7 January 2021

Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.904

1 reference

26 December 2017

1 reference

26 December 2017